NEW ISSUE
The ISCHEMIA trial in real-world practice, a new “uncaging” coronary stent, PCI of the LM trifurcation in the EXCEL trial and more...
December 18, 2020
1. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA; 2. Humanitas Clinical and Research Center IRCCS, Rozzano - Milan, Italy; 3. The Division of Cardiology, Faculty of Health Sciences, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa; 4. The Lambe Institute for Translational Research and CURAM, National University of Ireland Galway, Galway, Ireland; 5. Department of Health Policy, LSE Health, London, England; 6. AP-HP, URCEco, Hôpital de l’Hôtel Dieu, Université de Paris, CRESS, INSERM, INRA, Paris, France
Coronavirus disease 2019 (COVID-19) has exposed gaps in healthcare systems. Recognition of the impact of these gaps offers an opportunity for healthcare professionals working with political institutions to improve the intersection between health and society. Healthcare systems will need simultaneously to deal with non-COVID-19 chronic conditions (“the people left behind”) as well as maintain hospital facilities at a high level of preparedness for urgent care pandemic patients.
Chronic diseases account for 50-75% of total healthcare costs and the majority of deaths globally1,2,3,4. Current delivery models are poorly constructed to manage these chronic diseases with low adherence ...
Sign in to read and download the full article
Forgot your password?No account yet? Sign up for free!
Create my pcr account Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next article
Angiography-based quantitative flow ratio versus fractional flow reserve in patients with coronary artery disease and severe aortic stenosis